Response-guided bulevirtide ± pegylated interferon alfa-2a: Long-term outcomes observed in the nationwide Austrian hepatitis D cohort study. - Schwarz M; Hintersteininger M; Schwarz C; Panzer M; Pfisterer N; Loschko N; Hartl L; Dorn L; Laferl H; Trauner M; Stättermayer AF; Mandorfer M; et al. (JHEP reports : innovation in hepatology, 2026)